The purpose of the Program is to train scientists to conduct independent research related to the rheumatic diseases. The Program is centered in the Division of Rheumatology of the Department of Medicine (6000 square feet of laboratory space), and it is directed by Dr. Robert Eisenberg, Chief, Division of Rheumatology. It is administered by the Director and a Training Committee, consisting of the full time faculty of the Division, who together decide issues of recruitment, evaluation, guidance and training requirements. Support is requested for four post-doctoral fellows and two predoctoral trainees. Post-doctoral trainees will preferentially be drawn from individuals completing their Internal Medicine or Pediatrics residency, who apply for Rheumatology training, and who are clearly committed to a career biomedical research. Such individuals will be supported by institutional funds for an intense year of clinical Rheumatology, and then will move onto the training grant for 2-3 years of laboratory experience. Post-doctoral M.Ds who have completed their clinical subspecialty training or PhDs may also be directly recruited into preceptors' laboratories. Predoctoral trainees will be draw from the Immunology Graduate Program. Selection of candidates will be based on their proven commitment to research, their academic record, the quality of their past training, and letters of recommendation Trainees will linked by mutual consensus with individual preceptors, who will be largely responsible for guiding and supporting their research. Additional training will come from formal course work, weekly research and journal club conferences and the Immunology seminar series. Fellows will be encouraged and assisted in applying for supplemental funding to support further protected training beyond the time afforded by the T32. Clinical fellows on the training grant will have no mob than 10% of their time devoted to clinical care. The major areas of research training include immunology/molecular biology (Eisenberg, Erikson, Greene. Heber-Katz. Kieber-Emmons. Levinson, Madaio, Maul, Nowell, Schreiber, Silberstein, Weiner, Williams), cell biology/biochemistry (Douglas. Gaulton, Mellins, Monroe, SantoIi, Schumacher, Trinchieri), clinical research (Athreya, Callegari, Keenan, Schumacher, Von Feldt) and epidemiology (Grisso, Schwartz and Strom). The Division of Rheumatology is in an exciting growth phase with the recent addition of a new Chief, the potential to recruit 2- 3 more physician-scientists, and the assignment to new research space. This new energy will combine with the existing academic and clinical strengths at the University of Pennsylvania, to afford a Rheumatology training program of exceptional breadth and depth.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32AR007442-14
Application #
2909759
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Tyree, Bernadette
Project Start
1982-09-20
Project End
2001-04-30
Budget Start
1999-05-01
Budget End
2000-04-30
Support Year
14
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Gmuca, Sabrina; Yu, JiaDe; Weiss, Pamela F et al. (2018) Erythema Ab Igne in an Adolescent With Chronic Pain: An Alarming Cutaneous Eruption From Heat Exposure. Pediatr Emerg Care :
Sambamurthy, Nisha; Zhou, Cheng; Nguyen, Vu et al. (2018) Deficiency of the pattern-recognition receptor CD14 protects against joint pathology and functional decline in a murine model of osteoarthritis. PLoS One 13:e0206217
Yang, Ruili; Yu, Tingting; Kou, Xiaoxing et al. (2018) Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter. Nat Commun 9:2143
DeLong, Jonathan H; Hall, Aisling O'Hara; Konradt, Christoph et al. (2018) Cytokine- and TCR-Mediated Regulation of T Cell Expression of Ly6C and Sca-1. J Immunol 200:1761-1770
Grayson, Peter C; Eddy, Sean; Taroni, Jaclyn N et al. (2018) Metabolic pathways and immunometabolism in rare kidney diseases. Ann Rheum Dis 77:1226-1233
Mo, Charlie Y; Culyba, Matthew J; Selwood, Trevor et al. (2018) Inhibitors of LexA Autoproteolysis and the Bacterial SOS Response Discovered by an Academic-Industry Partnership. ACS Infect Dis 4:349-359
Gmuca, Sabrina; Xiao, Rui; Weiss, Pamela F et al. (2018) Use of Rituximab and Risk of Re-hospitalization for Children with Neuromyelitis Optica Spectrum Disorder. Mult Scler Demyelinating Disord 3:
Rood, Julia E; Burn, Thomas N; Neal, Vanessa et al. (2018) Disruption of IL-33 Signaling Limits Early CD8+ T Cell Effector Function Leading to Exhaustion in Murine Hemophagocytic Lymphohistiocytosis. Front Immunol 9:2642
Najem, Catherine E; Springer, Jason; Prayson, Richard et al. (2018) Intra cranial granulomatous disease in common variable immunodeficiency: Case series and review of the literature. Semin Arthritis Rheum 47:890-896
Sambamurthy, Nisha; Nguyen, Vu; Smalley, Ryan et al. (2018) Chemokine receptor-7 (CCR7) deficiency leads to delayed development of joint damage and functional deficits in a murine model of osteoarthritis. J Orthop Res 36:864-875

Showing the most recent 10 out of 93 publications